Rocket Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Rocket Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $9.09. The average 1-year stock price forecast is 295.26% higher than the current stock price, while the lowest is $4.00 (+73.91%) and the highest is $15 (+552.17%).

Price Target: $9.09 (+295.26%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$4.00	$9.09	$10	$15
Change	+73.91%	+295.26%	+334.78%	+552.17%

Analyst Ratings

The average analyst rating for Rocket Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	6	6	6	6	6	6
Buy	0	0	0	1	1	1
Hold	6	6	6	5	6	6
Sell	1	1	1	1	1	1
Strong Sell	1	1	1	1	0	0
Total	14	14	14	14	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mani Foroohar Leerink Partners	Leerink Partners	Hold Reiterates $4	Hold	Reiterates	$4	+73.91%	Nov 13, 2026
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Buy Maintains $10	Buy	Maintains	$10	+334.78%	Nov 13, 2026
Gil Blum Needham	Needham	Buy Maintains $9	Buy	Maintains	$9	+291.30%	Nov 13, 2026
Yun Zhong Wedbush	Wedbush	Buy Maintains $15 → $12	Buy	Maintains	$15 → $12	+421.74%	Nov 13, 2026
Joshua Schimmer Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $15	Buy	Reiterates	$15	+552.17%	Nov 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

935.18K

Revenue Next Year

11.25M

from 935.18K

1,102.46%

from 935.18K

EPS This Year

-0.11

from -1.98

EPS Next Year

-1.60

from -0.11

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	935.18K
Operating Income	-166.25M	-223.84M	-256.66M	-273.21M	-228.52M	-192.96M
Net Income	-169.07M	-221.86M	-245.60M	-258.75M	-223.12M	-18.41M
EPS	-	-	-	-	-1.98	-0.11
Free Cash Flow	-	-	-	-	-190.45M	-164.00M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	5.0M
Avg	935,180
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	3,035.4%
Avg	1,102.5%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	0.08
Avg	-0.11
Low	-0.20

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-